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SafetyWe aimed to investigate the feasibility of an experimental system for simultaneous transcranial DC stimula-
tion (tDCS) and EEG recording in human epilepsy. We report tolerability of this system in a cross-over con-
trolled trial with 15 healthy subjects and preliminary effects of its use, testing repeated tDCS sessions, in two
patients with drug-refractory Continuous Spike-Wave Discharges During Slow Sleep (CSWS). Our system
combining continuous recording of the EEG with tDCS allows detailed evaluation of the interictal activity dur-
ing the entire process. Stimulation with 1 mA was well‐tolerated in both healthy volunteers and patients
with refractory epilepsy. The large reduction in interictal epileptiform EEG discharges in the two subjects
with epilepsy supports further investigation of tDCS using this combined method of stimulation andmonitor-
ing in epilepsy. Continuous monitoring of epileptic activity throughout tDCS improves safety and allows de-
tailed evaluation of epileptic activity changes induced by tDCS in patients.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
The demonstration that electrical DC polarization of the brain is
able to change the neuronal discharges and evoked potentials in the
cortex was ﬁrst made invasively in small animals [1,2]. Whether an
increase or a suppression of neuronal activity was obtained depended
on the polarity of the electrodes. The fact that the cathode produces
suppression and the anode produces facilitation has been repeatedly
demonstrated [3]. The observation that persistent anodal stimulation
could produce paroxysmal activity, which could be suppressed by
cathodal stimulation [4], suggested that cortical polarization might
be a method with therapeutic applications in human epilepsy. The
demonstration that the effects on cortical excitability outlast the
stimulation period [5] further enhanced the expectations on the
potential usefulness of the method. One of the ﬁrst applications
in human subjects following these previous experimental studies
was in the ﬁeld of mental illness [6,7]. Although there were positive
studies in some of the initial trials [8], results at this time are mixed
(reviewed in [9]).na, Alto do Vieiro, 2411‐901
rights reserved.The recent use of neurophysiological methods to optimize the
effects of tDCS in human subjects increased the clinical efﬁcacy of
this method [10–14] and has generated a renewed interest in the
methodology of polarizing the brain to induce functional changes. In
fact, the ability of tDCS to modulate the relation between cortical
excitation and inhibition can be of potential usefulness in human
epilepsy, a clinical condition where this relation is pathologically
unbalanced. Recent demonstrations of the ability of weak direct cur-
rents to modulate epileptiform activity in animal models of epilepsy
were done, both in vitro [15] and in vivo [16]. Despite the encouraging
results of the method, several practical issues remain unanswered,
and until recently only four studies [17–20] have directly applied tDCS
to patients with epilepsy. Indeed, the signiﬁcant reduction in EEG epi-
leptiform discharges in this study, after only one stimulation session
(20 min, 1 mA), led us to test for enhanced methods to deliver tDCS
in patients with epilepsy.
Given that the clinical use of tDCS in patientswith epilepsy requires a
detailed evaluation of its safety and tolerability proﬁle, we present a sys-
tem thatmayovercome some of the identiﬁed problems associatedwith
the application of tDCS in human epilepsy using combined EEG–tDCS
application. With this system it is possible to 1) continuously record
the epileptogenic activity during the tDCS session; 2) reliably quantify
the interictal events; and 3) optimize the stimulation electrodes con-
ﬁguration for different locations of the epileptogenic foci. In this study,
418 P. Faria et al. / Epilepsy & Behavior 25 (2012) 417–425our goals were to (i) present a detailed explanation of this system;
(ii) report its use and tolerability in ﬁfteen healthy subjects; and (iii)
preliminarily test its use in two subjectswith epileptic encephalopathies
and Continuous Spike-Wave Discharges During Slow Sleep (CSWS), as a
proof-of‐concept of this combined tDCS–EEG system.
2. Methods
2.1. Participants and patients’ descriptions
A group of 15 healthy volunteers (ages 20 to 32 years) was sub-
mitted to the initial tests, with simultaneous recording of the EEG
and tDCS. The goals of this experiment were as follows: (i) to test
the tolerability of the stimulation over the central areas with currents
of up to 1 mA and (2) to test the ability to recover a clean EEG
recorded from electrodes near the stimulation points. We also tested
our system in two patients with epileptic encephalopathy.
2.1.1. Patient 1
Patient 1 was an 11‐year-old male with CSWS and severe behav-
ioral problems. A detailed clinical study of the patient that included
long-term EEG monitoring demonstrated a persistent paroxysmal
interictal activity in the central regions of both hemispheres during
wakefulness that signiﬁcantly increased, becoming almost continu-
ous during sleep. A detailed characterization of the type and spatial
distribution of the paroxysms on the scalp was obtained using
high-resolution EEG with 82 electrodes. This study revealed the
maxima of epileptiform EEG discharges in the regions of C5 and C4
of the 10–10 international system (Figs. 1a and 2a). A detailed anal-
ysis of the temporal evolution of electric potential topography
throughout the epileptiform EEG discharges resulted in identiﬁca-
tion of two independent foci, one in each hemisphere (Fig. 2a). The
MRI failed to demonstrate any structural lesion. The epilepsy of this
patient proved refractory to pharmacologic therapy, and he was pre-
viously found not to be a candidate for epilepsy surgery.
2.1.2. Patient 2
Patient 2 was a 7‐year-old male with Landau–Kleffner syndrome
(LKS). This syndrome typically appears in previously healthy individuals
that progressively lose receptive and expressive language, whichFig. 1. Map of the electric potential of patients 1 (a) and 2 (b) on the highest value of the pa
cording and tDCS. A cap with electrodes at the 10–10 system positions was used, with the t
placed on its adaptor is shown in the inset.coincides with the appearance of paroxysmal activity in the EEG over
the cortical language regions [21]. A detailed neurophysiological study
of the patient showed moderate paroxysmal activity in the central
regions of both hemispheres during wakefulness that increased sig-
niﬁcantly during sleep, evolving to CSWS. The high‐resolution EEG
localized two types of epileptiform EEG discharges with distinct
topography and maxima in the regions of electrodes C5 and C6 of the
10–10 international system (Figs. 1b and 2b). The analysis of the tem-
poral evolution of electric potential topography throughout the epilep-
tiform EEG discharges identiﬁed an early focus in the left hemisphere
(Fig. 2b) with secondary bilateral synchronization to the right hemi-
sphere epileptiform EEG discharges. The MRI of patient 2 failed to
demonstrate any structural lesion. The epilepsy of this patient also
proved refractory to pharmacologic therapy, and he previously been
found not to be a candidate for epilepsy surgery.
2.1.3. Ethical considerations
Written informed consent was obtained from the patients’ legal
guardians and from all volunteers. This study was approved by the
local ethics committee (CentroHospitalar Psiquiátrico de Lisboa, Lisbon,
Portugal).
2.2. EEG recording and processing
The EEG was recorded with AgCl sintered ring electrodes, 1.18 cm
in diameter, snapped into adaptors placed at the 10–10 system posi-
tions in a cap (Easycap, Herrsching-Breitbrunn, Germany), as shown
in Fig. 1c.
The scalp under each electrode was prepared with an abrasive
compound (Skin Pure, Nihon Kohden Inc., Japan), and afterwards,
a conductive gel (Electrocap Inc., Eaton, USA) was applied in each
electrode. Stable impedances below 5 kΩ were consistently obtained.
The signal was recorded with a 32-channel AC electroencephalograph
(SynAmps, Neuroscan, Charlotte, USA), using a sampling rate of 500 Hz
and high‐ and low-pass ﬁlters set to 0.5 and 70 Hz, respectively. The
reference and ground electrodes were placed in the mastoid area
contralateral to the stimulated hemisphere, and 24 EEG electrodes
were used for recording (F8, F4, Fz, F3, F7, FC4, FC3, T4, C6, C4, C2, C1, C3,
C5, T3, CP4, CP3, T6, P4, Pz, P3, T5, O2, O1).roxysm at C5 (left epileptiform EEG discharges). (c) A patient’s preparation for EEG re-
hree anodes (A) at FP1, FPz, and FP2 and the cathode (C) placed at CP5. A ring electrode
Fig. 2. Characterization of the temporal evolution of electric potential topography of patient 1 (a) and patient 2 (b) between the beginning and the end of the paroxysms.
(a) Allows the identiﬁcation of a stable topography in both hemispheres and shows that there is no evidence of any contralateral propagation. (b) Allows the identiﬁcation
of a stable topography in the left paroxysms but a topography with a contralateral initial component in the right paroxysms. This observation demonstrates the existence of
a bilateral synchronization through the left hemisphere. The asterisks on the ﬁgure identify the electric potential topography which corresponds to the closest point to the
maximum value of the paroxysm.
419P. Faria et al. / Epilepsy & Behavior 25 (2012) 417–425During tDCS, our constant current source (i.e., the DC stimulator,
Phoresor 850, Iomed Inc., Salt Lake City, USA) constantly adjusted
the potential difference between the two stimulation electrodes inorder to keep the intensity of the injected current constant. The visual
analysis of the EEG revealed a high-frequency artifact in the elec-
trodes in the neighborhood of the cathode. These artifacts were due
420 P. Faria et al. / Epilepsy & Behavior 25 (2012) 417–425to a very small AC component with a 12 Hz multiple period charac-
teristic of the Phoresor 850 functioning. Online removal of the artifact
induced by the tDCS was performed using the Acquire 4.3.3 software
package developed by Neuroscan (Neuroscan, Charlotte, NC, USA) to
remove gradient artifacts in the MRI environment with appropriate
adjustment of the relevant parameters. The online removal of the ar-
tifact signiﬁcantly improved the readability of the EEG, but several
high‐amplitude transients remained that could interfere with the cor-
rect quantiﬁcation of the epileptic activity in epilepsy patients. There-
fore, ofﬂine artifact removal was performed using the Independent
Component Analysis (ICA) with the Informax algorithm of EEGLAB
[22]. The coefﬁcients of ICs with temporal dynamics closely matching
those of the DC artifact, evaluated on simultaneous visual inspection,
were set to zero and the ﬁltered signal was reconstructed. The ofﬂine
removal based on ICA proved to be much more powerful in extracting
the induced artifact, effectively recovering a clean EEG, even in the
electrodes close to the cathode (Fig. 3).
2.3. Transcranial DC stimulation
DC current was applied through sintered AgCl electrodes such
as the ones used for EEG recording (Fig. 1c). The scalp preparation
and the application of conductive gel were performed as for the EEG
electrodes, with impedances kept below 5 kΩ. Current was delivered
by a Phoresor 850 current source, which provides currents up to
4 mA, with the possibility of ramping the intensity up and down in
steps of 0.1 mA. In the present study, the current intensity used never
exceeded 1 mA.
In both experiments (the one with the 15 healthy volunteers
and the other with the patients with epilepsy), the three adjacent
electrodes were shorted together and used as anodes (arrow A in
Fig. 1c) and a unique electrode as cathode (arrow C in Fig. 1c), in
order to decrease the intensity of anodal stimulation. In the healthy
subjects experiment, they were placed close to the usual location
for the stimulation of central areas – FP1, FPz, and FP2 (i.e., above con-
tralateral eyebrow) – and for the same reason and also because no
epileptogenic activity was apparent in the region of the anodes,
they were positioned at the same place in the two subjects with epi-
lepsy [11,23]. In the study of volunteers, the cathode was placed at a
location (CP6) optimized for the stimulation of central areas in the
left hemisphere, and in patients at CP5, as indicated by arrow C in
Fig. 1c. In the study of patient 1, we chose to stimulate the left hemi-
sphere because he had two independent foci, one in each hemisphere.
The right hemisphere was used as a control for this patient (Fig. 2a).
In the study of patient 2, we chose to stimulate the left hemisphereFig. 3. EEG from a volunteer before (a) and during (b) tDCS at 1 mA. A large artifact during
scale 200 μV). (c) Ofﬂine removal of the artifact allows a clear reading of the EEG throughobecause it was the origin of both types of epileptiform EEG discharges
(Fig. 2b). In both studies (the one with volunteers and the one
with the patients with epilepsy), the goal was to induce local inhibi-
tion with cathodal stimulation (anodal was considered the reference
electrode and thus placed in a silent area). Current was ramped in
steps of 0.1 mA, with a duration of 10 s each, until the target current
of 1 mA.
The parameters of tDCS were deﬁned as follows:
Experiment with healthy subjects: The experimental protocol
involved three afternoon sessions per subject, each one of 15 min.
In each session, EEG was continuously recorded through a resting
period of 5 min, followed by the application of a constant current
of 0.5 mA, 1 mA, or shamduring 5 min, and a ﬁnal EEG resting peri-
od of 5 min. Subjects were unaware of the current intensity applied.
The order of stimulation was randomized and counterbalanced
across subjects. In the sham session, the current was ramped up
to 0.5 mA and down to 0 at the beginning of the session. A recovery
period of 15 min was imposed between sessions. After each session,
the volunteer classiﬁed the tolerability of the tDCS protocol in a
scale of 1 to 5, where 1 was “I didn't feel anything” and 5 was
“Intolerable”.
Experimental protocol for patients with epilepsy: Patients were
submitted, once weekly, to three afternoon sessions of 30 min
each. The protocol began immediately after the patient reached
Stage 2 sleep, evaluated online by the clinical neurophysiologist
(A.L.). In the ﬁrst timepoint (timepoint 1 — baseline), the EEG was
recorded during 10 min, after that, a current of 1 mA was injected
during 10 min (timepoint 2 — during tDCS), and afterwards, the
EEGwas recorded during the last 10 min (timepoint 3— post-tDCS).
Because the goal was to conduct an initial assessment of this system
in human epilepsy, we only tested active tDCS sessions so as to
provide initial proof-of-principle data.
2.4. Data analysis
The effects of tDCS in the paroxysmal activity of the two patients
with epilepsy studied at C5 and C4 (patient 1) and C5 and C6 (patient
2) were analyzed through the quantiﬁcation of the number of epilepti-
form EEG discharges per minute during the 10 min before (timepoint
1), during (timepoint 2), and after (timepoint 3) the tDCS session, in
the three sessions performed. A single electrode was used to quantify
a particular epileptiform EEG discharge type, and the selection was
based on an amplitude criterion in which the highest amplitude
electrode for each epileptiform EEG discharge type was used fortDCS completely prevents evaluation of EEG features (horizontal scale 500 ms, vertical
ut the stimulation period.
P. Faria et al. / Epilepsy & Behquantiﬁcation purposes. Note that this quantiﬁcation process was
only done when the patient was sleeping, which was conﬁrmed by
the neurophysiologist (A.L.) through the reading of the physiological
wave patterns in the EEG. Statistical analysis was performed with the
SPSS Statistics 17.0 (Chicago, Illinois, USA). Besides descriptive statis-
tics, we used nonparametric tests; namely, the Mann–Whitney, the
Kruskal–Wallis, and the Wilcoxon tests since the sample size for each
patient is less than or equal to 30, and also because data normality is
not veriﬁed in each timepoint. All the results were analyzed for a statis-
tical signiﬁcance level of 5%.
3. Results
3.1. Tolerability
The results from the 15 healthy volunteers revealed that tDCS,
when current up to 1 mA is used, is a technique with high levels of
tolerability, with only 2 of them reporting a mild discomfort when
the maximal current of 1 mA was used. With 1 mA tDCS, participants
reported DC application as “I didn't feel anything” (13%), “I felt some-
thing” (40%), and “Tolerable” (33%) and none of them categorized it
as “intolerable”. When a current of 0.5 mA was used, only one partici-
pant reported this stimulation as “uncomfortable” and none considered
this session “intolerable”. The sham tDCS session conﬁrmed what was
expectable, i.e., 93% of the participants did not feel anything; though
some still reported a sensation.
3.2. Quantiﬁcation of tDCS response on the epileptiform EEG activity
Both patients tolerated the procedurewell and reported that they felt
something trying to wake them up, when the current was initially
ramped up to 1 mA. Nevertheless, most of the times (5 out of 6
sessions) after a couple of minutes, they fell asleep. No adverse effects
and no complex partial seizures or secondarily generalized seizures oc-
curred before, during, or after the stimulation. The EEG obtained after
ofﬂine artifact removal allowed the quantiﬁcation, by an expert clinical
neurologist (A.L.), of the tDCS response on the paroxysmal activity of
the three sessions performed by the two patients. In this quantiﬁcation
process, an average referencemontage in electrodes C5 andC4, for patient
1, and C5 and C6, for patient 2, was continually used during each session.
For simplicity, we will use the notation CxSy to indicate that the quantiﬁ-
cation was made at electrode Cx in session y, for x(electrode)={4,5,6}
and y(session)={1,2,3}, depending on each patient.
3.2.1. Quantiﬁcation of the number of epileptiform EEG discharges for
patient 1
The number of epileptiform EEG discharges perminute at electrodes
C5 and C4 was counted only when patient 1 was asleep. In timepoints 1
and 2 (baseline and during tDCS), for the three sessions, it was recorded
for 10 min; except for sessions 2 and 3 (of timepoint 2), in which
only 8 min was recorded. It was not possible to analyze the number of
epileptiform EEG discharges in timepoint 3 (post-tDCS) for the three
sessions, because the patient was awake, and did not return to sleep,
making the quantiﬁcation process impossible (Figs. 4a–b). Note also
that this patient only had continuous paroxysmal activity during sleep
(the visualization of the EEG physiologic sleep patterns was used to
recognize the occurrence of sleep).
3.2.1.1. Data analysis— patient 1. Fig. 5a shows the temporal evolution
of the average number of interictal epileptiform EEG discharges
per minute at electrodes C5 (Fig. 5a, up) and C4 (Fig. 5b, down) of
timepoint 1 (before DC) and timepoint 2 (during DC) for the three
sessions performed. The results show a reduction on the average
number of epileptiform EEG discharges at electrode C5, from
timepoint 1 to timepoint 2, of 61%, 16%, and 32%, in the three sessions,
respectively. At electrode C4 (contralateral hemisphere), almostminimal change was found. The standard deviation of the number
of epileptiform EEG discharges per minute of timepoints 1 and 2 in
the three tDCS sessions was also counted at both electrodes C5 and
C4, and it was smaller in timepoint 1 (C5S1: 6.2, C5S2: 6.4, C5S3: 9.6,
C4S1: 6.2, C4S2: 12, C4S3: 14.4) when compared with the values
obtained in timepoint 2 (C5S1: 22.4, C5S2: 15.4, C5S3: 13, C4S1: 45,
C4S2: 6.1, C4S3: 14.5), except on C4S2. The dispersion of the number
of epileptiform EEG discharges counted at electrodes C5 (Fig. 5c, up)
and C4 (Fig. 5c, down), in both timepoints 1 and 2, in the three ses-
sions was analyzed and can be seen in Fig. 5c. The boxplots obtained
present a low dispersion before tDCS in both hemispheres. The dis-
persion increases during tDCS when compared to the previous period,
mainly in session 1. A moderate outlier (black dot) was observed and
kept in the analysis.
The nonparametric Mann–Whitney test was used to investigate
whether there was a signiﬁcant change in epileptiform EEG dis-
charges when comparing across C5S1, C5S2, C5S3, C4S1, C4S2, and
C4S3, considering timepoints 1 and 2 (before and during tDCS, respec-
tively) of the three sessions at electrodes C5 and C4. The results for the
C5 electrode show that there is a signiﬁcant decrease in the number
of epileptiform EEG discharges between timepoint 1 (before tDCS)
and timepoint 2 (during tDCS) in all sessions (p-value≈0, p-value=
0.013, and p-value=0.026, respectively), whereas, the results related
to electrode C4 show that the number of epileptiform EEG discharges
per minute is not signiﬁcantly different between timepoints 1 and 2
in all sessions (p-value=0.940, p-value=0.090, and p-value=0.423,
respectively).
We also used the nonparametric Wilcoxon test (paired samples)
to compare the number of epileptiform EEG discharges per minute
in the same session in both hemispheres and both timepoints 1 and
2, i.e., the pairs C5S1–C4S1, C5S2–C4S2, and C5S3–C4S3. The results
showed the following:
1) before tDCS — in the two ﬁrst sessions, no signiﬁcant differences
were found in both hemispheres (p-value≈1 and p-value=
0.079, respectively), whereas, in session 3 there were signiﬁcant
differences in both hemispheres (p-value=0.012);
2) during tDCS — signiﬁcant differences were found across the three
sessions when comparing both hemispheres (p-value=0.005 in
all sessions).
3.2.2. Quantiﬁcation of the number of epileptiform EEG discharges for
patient 2
The number of epileptiform EEG discharges per minute at elec-
trodes C5 and C6 was counted during the 10 min of the three
timepoints [before (1), during (2), and after (3) tDCS, respectively]
for sessions 2 and 3. Figs. 4c–d shows the temporal evolution of the
number of epileptiform EEG discharges only for sessions 2 and 3
because on the ﬁrst session the patient did not sleep, making the
quantiﬁcation process impossible.
3.2.2.1. Data analysis— patient 2. Fig. 5b shows the temporal evolution
of the average number of interictal epileptiform EEG discharges
per minute at electrodes C5 (Fig. 5b, up) and C6 (Fig. 5b, down) of
timepoint 1 (before DC), timepoint 2 (during DC), and timepoint 3
(after DC) for sessions 2 and 3. The results show a reduction of the
average number of epileptiform EEG discharges at electrode C5 (50%
and 42% reduction from timepoint 1 to timepoint 2 and 6% and 14%
from timepoint 2 to timepoint 3; of sessions 2 and 3, respectively).
A similar reduction of the average number of epileptiform EEG dis-
charges at electrode C6 (contralateral hemisphere) of 54% and 47%,
from timepoint 1 to timepoint 2, and of 6% and 16%, from timepoint
2 to timepoint 3, of sessions 2 and 3, respectively, was found. The
standard deviation of the number of epileptiform EEG discharges
per minute on the three timepoints of sessions 2 and 3, at electrodes
C5 and C6, was also quantiﬁed; showing also a decrease over time
421avior 25 (2012) 417–425
Fig. 4.Number of epileptiform EEG discharges of patient1 and patient 2 per minute measured at electrodes C5 (a) and C4 (b) and C5 (c) and C6 (d), respectively, before (timepoint 1),
during (timepoint 2), and after (timepoint 3) DC stimulation for the three sessions performed. The quantiﬁcation was only made during patients' sleep. In each ﬁgure the vertical
line separates the three timepoints analyzed.
422 P. Faria et al. / Epilepsy & Behavior 25 (2012) 417–425(timepoint 1: C5S2: 13.7, C5S3: 11.9; C6S2: 16.8, C6S3: 13.6; timepoint 2:
C5S2: 6.6, C5S3: 5.3; C6S2: 6.4, C6S3: 6; and timepoint 3: C5S2: 5.7, C5S3:
3.3; C6S2: 5.5, C6S3: 2.8).
The dispersion of the number of epileptiform EEG discharges
counted on electrodes C5 (Fig. 5d, up) and C6 (Fig. 5d, down) at
each of the three timepoints of sessions 2 and 3 was analyzed and
can be seen in Fig. 5d. The boxplots present a higher dispersion before
tDCS in both hemispheres. The dispersion gets signiﬁcantly low
during DC stimulation when compared to the previous period and
keeps almost stable between timepoint 2 (during tDCS) and timepoint
3 (after tDCS). Somemoderate (black dot) and severe (black asterisks)
outliers were observed and kept in the analysis. Due to the irregularity
of the paroxysmal activity, two severe outliers found in C5S3 (black
asterisks), during tDCS, were kept in the analysis.
The nonparametric Kruskal–Wallis test showed that there was
statistical evidence to say that at least one timepoint is signiﬁcantly
different than the other timepoints in the two sessions and both
hemispheres (all the p-values were approximately zero). Pairwise
comparisons show that there were signiﬁcant differences for thenumber of epileptiform EEG discharges per minute between the
timepoints: before–during and before–after in both sessions (all the
p-values were approximately zero). We also found signiﬁcant differ-
ences on session 3, at the pairwise comparison during–after in both
hemispheres (p-value=0.003 at C5, p-value=0.020 at C6).
We also used the nonparametric Wilcoxon test (paired samples)
to compare the number of epileptiform EEG discharges per minute
in both hemispheres and in the same session, i.e., the pairs C5S2–
C6S2 and C5S3–C6S3 in the three timepoints. The results showed the
following:
1) before and during tDCS — no signiﬁcant differences were found be-
tween the same sessions of different hemispheres (timepoint 1:
p-value=0.508 and p-value=0.674; timepoint 2: p-value≈1
and p-value=0.075, in sessions 2 and 3, respectively);
2) after tDCS — in session 2, no signiﬁcant differences were found
in both hemispheres (p-value≈1), whereas, in session 3, there
were signiﬁcant differences when comparing both hemispheres
(p-value=0.007).
Fig. 5. The temporal evolution of the average of the number of epileptiform discharges per minute of patient 1 at electrodes C5 and C4 (a) and of patient 2 at electrodes C5 and C6
(b) at timepoints 1, 2, and 3 (before, during, and after DC stimulation). Boxplots of the number of epileptiform discharges per minute of both patients at electrodes C5 and C4
at timepoints 1 and 2 (before and during DC stimulation) of the three sessions (patient 1, (c)), and at electrodes C5 and C6 at timepoints 1 to 3 (before, during, and after DC
stimulation) of sessions 2 and 3 (patient 2, (d)).
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We implemented a system that allows the EEG to be recorded
during tDCS and performed a controlled trial in healthy subjects to
test the tolerability of this system and a proof-of-principle experi-
ment in patients with focal refractory epilepsy. As far as we know,
no studies have applied tDCS simultaneously with the EEG recording
in patients with refractory epilepsy to date; therefore, we report the
ﬁrst study investigating the feasibility and proof-of-concept of tDCS
in two patients with epileptic encephalopathies with CSWS, using
the EEG recording concomitantly with tDCS. In the literature, to our
knowledge, there is one study using EEG recording [17] but only
before, immediately after, and a few days after tDCS.
The main motivation for developing this system was to assess
safety during the application of tDCS in patients with epilepsy. This
is particularly important given that effects of tDCS are widespread
[24–27], and in fact, it induced simultaneously an increase and de-
crease of cortical excitability if a cephalic montage is used. Cathodal
stimulation usually results in decreased excitability and neuronal
discharge [1,2,5], and this effect has been demonstrated to depend
on the direction of the current [2,3] and the orientation of the cortical
surface relative to the current sources. In humans, the highly convo-
luted nature of the cortical surface makes it difﬁcult to predict the
effect of tDCS on cortical excitability. In this setting, the continuous
recording of EEG during stimulation offers a means for quick assess-
ment of the effect of stimulation and the timely detection of undesirable
responses.
With the current technology, it is not possible to calculate the
intracranial distribution of the electric ﬁeld in tDCS in vivo, though
we use the previous modeling work [23,27,28] to choose the best
electrode conﬁguration with EEG electrodes taking into account the
region of the epileptic foci of patients and the value of the injected
current.
The use of EEG electrodes for stimulation facilitates the integration
of the recording and stimulation procedures. However, the main ad-
vantage of this system is that the recording and the stimulation elec-
trodes can all be placed close to the scalp projection of the cortical
epileptic focus and within a few centimeters of each other, thus in-
creasing the efﬁcacy of stimulation and the sensitivity of the recording
of the interictal activity, in a way that would not have been possible
with the conventional large stimulation electrodes. Also, stimulation
is more focal not only in the sense that a smaller brain volume under
the EEG electrode is affected than when large electrodes are used
(see [23,27,28]), but also in the sense that the current density under
the single cathode is higher than under the larger anode electrode
(using three EEG electrodes together). In fact, a few studies have
shown that this method of stimulation (using small electrodes —
also called HD-tDCS) is associated with signiﬁcant effects on cortical
excitability and pain threshold [29,30].
The main drawback of using EEG electrodes for stimulation is the
higher electric ﬁeld in the scalp. The magnitude of the electric ﬁeld
at the edge of the electrode in contact with the scalp was estimated
to be a factor of 6 larger than in the traditional conﬁguration of two
35 cm2 electrodes placed over the frontal and motor cortices [27].
On the other hand, the electrode-skin impedance can be easily moni-
tored using the EEG recording system, and a low resistance (b5 kΩ)
can be guaranteed. Additionally, there is a good temporal stability in
the contact between the gel and the scalp and a more uniform contact
between the two.
The study in 15 volunteers revealed good tolerability to currents
of 1 mA using small electrodes. The low electrode-skin impedance
as well as a more stable electrical connection to the scalp provided
by the EEG gel as compared to the saline solution used in current
experimental systems are improvements that, in our view, make
the stimulation procedure more reliable. However, one signiﬁcant
issue with this design is blinding, since most of the healthy subjectsdetected and reported some sensation during active stimulation.
Similar to the situation for repetitive transcranial magnetic stimula-
tion (rTMS), it may not be possible to fully blind subjects who under-
go this method of EEG recording and application of tDCS with small
electrodes.
The application of the presented system allowed a detailed quan-
tiﬁcation of the interictal paroxysmal activity in two patients with
refractory epilepsy such as CSWS during slow-wave sleep and Lan-
dau–Kleffner syndrome. The temporal evolution of the number of ep-
ileptiform EEG discharges per minute at electrodes C5 and C4 (patient
1) and C5 and C6 (patient 2), during the 10 min before, during and
after tDCS, in the three sessions is presented in Fig 4. As the paroxys-
mal activity was evaluated only during sleep, in some of the sessions
the quantiﬁcation process was not possible (after stimulation in pa-
tient 1).
This proof‐of‐principle investigation showed that tDCS is able to
modulate the paroxysmal interictal activity in human epilepsy.
Although our preliminary results have very limited data samples,
they seem to conﬁrm the notion that tDCS using smaller electrodes
can also decrease the number of epileptiform discharges. The analysis
of tDCS response in paroxysmal activity in patient 1 shows a reduction
of approximately 40% from timepoint 1 to timepoint 2 of the number
of epileptiform EEG discharges at electrode C5 in the three sessions
held. The paroxysmal activity in electrode C4, on the contralateral
hemisphere, where the tDCS was not performed, did not change;
thus, showing a focal effect of tDCS. The quantiﬁcation of the number
of epileptiform EEG discharges of patient 2 shows a reduction of ap-
proximately 50%, from timepoint 1 to timepoint 2, of the paroxysmal
activity, at electrode C5, which was consistent in the three sessions
performed. This paroxysmal activity reduced around 10% even after
tDCS. The contralateral paroxysmal activity, measured at electrode
C6, declined in a very similar way. In both patients, the results were
in agreement with the characteristics of each patient’s epileptic foci.
Although at ﬁrst glance the opposite change in dispersion of the data
associated with tDCS between the two patients seems to indicate
opposite results, they, in fact, represent improvement in both cases.
The reason for the different results is based on the opposite baseline
dispersion of the data.
The previous results are in contrast with the results of Varga et al.
[20], which found no effect of 20-minute tDCS in epileptiform
EEG discharge reduction in a similar group of patients to our own.
Stimulation was performed with the patients awake, and no record-
ing of EEG during stimulation was performed. Other differences to
our work are a less precise localization of the foci (based on 19 elec-
trodes) and a less focal stimulation, as well as the fact that we quanti-
ﬁed epileptiform EEG discharges during and immediately after tDCS,
which was applied during sleep. Overall, the two studies recorded
epileptiform EEG discharge rates at different times in relation to
tDCS which prevents a direct comparison of results. Finally our results
are preliminary due to the limited data analyzed.
The results obtained for patients 1 and 2 are encouraging and
demonstrate that it is possible to implement a tDCS system that is
safe and well‐tolerated and has enough cortical polarization power
to modulate epileptic activity focally. Because the cognitive and
functional development of these patients are strongly affected by
the paroxysmal activity [31], any contribution for its reduction may
result in cognitive and functional gain for the patient. Nevertheless,
the preliminary results from these two cases needs to be tested in a
randomized sham-controlled trial properly powered. In addition,
further studies should assess cognitive function before and after
tDCS to investigate in detail the potential clinical gains of tDCS in the
cognitive and functional realms.
In summary, the ﬁndings of our study suggest that cathodal DC
is safe and well‐tolerated in patients with refractory epilepsy. The
preliminary results from these two subjects conﬁrmed that this tech-
nique decreased the excitability in the epileptogenic focus focally,
425P. Faria et al. / Epilepsy & Behavior 25 (2012) 417–425which is encouraging for the use of this technique in epilepsy. The
proposed system opens interesting perspectives for the application
of tDCS in the modulation of the epileptogenic foci in humans,
allowing a detailed characterization of the EEG activity during the
stimulation procedure and resulting in increased sensitivity and
safety.
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